NEW YORK (GenomeWeb) – The US Food and Drug Administration indicated last week that it doesn't want to dictate analytical standards to developers of next-generation sequencing tests, but would rather the experts come up with them as a community.
NEW YORK (GenomeWeb) – The US Food and Drug Administration indicated last week that it doesn't want to dictate analytical standards to developers of next-generation sequencing tests, but would rather the experts come up with them as a community.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.